News

ascopubs.org18h
Amivantamab monotherapy in relapsed/refractory metastatic colorectal cancer: OrigAMI-1, an open-label, phase 1b/2 study.
Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations. A phase II trial of TAS-102 in patients with colorectal cancer ...
The Lancet3d
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label ...
aState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China bState Key ...
National Security Journal on MSN4d
The B-1B Lancer Bomber Has a Message for China’s Military
In a potential conflict with peer adversaries like China or even Russia, the US Air Force’s B-1B Lancer bombers are expected ...